PL438650A1 - Sposób wytwarzania kompleksów białek z lipopolisacharydami bakteryjnymi, ich zastosowanie, szczepionka zawierająca immunogenny kompleks LPS/białko i sposób wytwarzania szczepionki - Google Patents

Sposób wytwarzania kompleksów białek z lipopolisacharydami bakteryjnymi, ich zastosowanie, szczepionka zawierająca immunogenny kompleks LPS/białko i sposób wytwarzania szczepionki

Info

Publication number
PL438650A1
PL438650A1 PL438650A PL43865021A PL438650A1 PL 438650 A1 PL438650 A1 PL 438650A1 PL 438650 A PL438650 A PL 438650A PL 43865021 A PL43865021 A PL 43865021A PL 438650 A1 PL438650 A1 PL 438650A1
Authority
PL
Poland
Prior art keywords
vaccine
producing
lps
proteins
protein complex
Prior art date
Application number
PL438650A
Other languages
English (en)
Other versions
PL246286B1 (pl
Inventor
Tomasz LIPIŃSKI
Jakub Siednienko
Original Assignee
Biovetika Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovetika Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biovetika Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL438650A priority Critical patent/PL246286B1/pl
Priority claimed from PL438650A external-priority patent/PL246286B1/pl
Priority to PCT/IB2022/057067 priority patent/WO2023007456A1/en
Publication of PL438650A1 publication Critical patent/PL438650A1/pl
Publication of PL246286B1 publication Critical patent/PL246286B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem wynalazku jest sposób wytwarzania kompleksów immunologicznych lipopolisacharyd bakteryjny (LPS)/białko, zastosowanie kompleksu LPS/białko do indukcji odpowiedzi immunologicznej, sposób wytwarzania szczepionki weterynaryjnej zawierającej kompleks immunologiczny LPS/białko oraz szczepionka weterynaryjna wytwarzana tym sposobem.
PL438650A 2021-07-30 2021-07-30 Sposób wytwarzania kompleksów białek z lipopolisacharydami bakteryjnymi, ich zastosowanie, szczepionka zawierająca immunogenny kompleks LPS/białko i sposób wytwarzania szczepionki PL246286B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL438650A PL246286B1 (pl) 2021-07-30 Sposób wytwarzania kompleksów białek z lipopolisacharydami bakteryjnymi, ich zastosowanie, szczepionka zawierająca immunogenny kompleks LPS/białko i sposób wytwarzania szczepionki
PCT/IB2022/057067 WO2023007456A1 (en) 2021-07-30 2022-07-29 A method for producing complexes of proteins with bacterial lipopolysaccharides, the use thereof, a vaccine comprising an lps/protein immunogenic complex and a method for producing the vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438650A PL246286B1 (pl) 2021-07-30 Sposób wytwarzania kompleksów białek z lipopolisacharydami bakteryjnymi, ich zastosowanie, szczepionka zawierająca immunogenny kompleks LPS/białko i sposób wytwarzania szczepionki

Publications (2)

Publication Number Publication Date
PL438650A1 true PL438650A1 (pl) 2023-02-06
PL246286B1 PL246286B1 (pl) 2024-12-30

Family

ID=

Also Published As

Publication number Publication date
WO2023007456A1 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
BR112022001185A2 (pt) Método de eliciamento de uma resposta imune administrando uma população de polimerossomos tendo um antígeno associado com uma população de polimerossomos tendo um adjuvante associado, bem como composições compreendendo as duas populações de polimerossomos
AR127585A1 (es) Vacuna de arn de virus sincicial respiratorio
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
BR112024001911A2 (pt) Vacinas de rna
CY1119822T1 (el) Συνθεση εμβολιου περιεχουσα συνθετικο ανοσοενισχυτικο
PE20212265A1 (es) Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos
ATE426412T1 (de) Adjuvante influenza-vakzine
EA201800067A1 (ru) Полисахаридные вакцинные препараты и способ промышленного получения бактериальных полисахаридов
DOP2018000259A (es) Proteínas de unión biespecíficas que se unen a una proteína inmunomoduladora y a un antígeno tumoral
MX2024006506A (es) Vacunas basadas en vectores virales de metapneumovirus humano.
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EA201991843A1 (ru) Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов
MX377803B (es) Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas.
WO2021202599A3 (en) Adeno-associated virus based compositions and related methods for inducing humoral immunity
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
BR112023027312A2 (pt) Imunocitocina
EA201792512A1 (ru) Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
JOP20190038B1 (ar) تركيب اقتراني من السكر المتعدد لكبسولة بكتيريا المكورات الرئوية وبروتين حامل واستخداماته
WO2024163508A3 (en) Methods and compositions for quadrivalent influenza vaccine
EA202091435A1 (ru) Оптимизированная система вектор-хозяин для получения защитной моно- и поливалентной субъединичной вакцины на основе дрожжей kluyveromyces lactis
WO2018066948A3 (ko) 다수의 에피토프로 구성된 재조합 항원 단백질 및 이의 제조방법
CN110191719A (zh) 重组rsv抗原
MX2021015155A (es) Polisacaridos de ramnosa.
UY40626A (es) Métodos y composiciones para la vacuna tetravalente contra la influenza
Paci et al. Proteomic analysis of immunoreactive proteins of Brucella melitensis to be used in diagnostic tests.